glp-1 medications and alcohol GLP‐1 Receptor Agonists for Treating Use Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical Experimental Research GLP-1 Drugs May Help Reduce

Description

Gallbladder-related events, including cholelithiasis and cholecystitis, occur more frequently with GLP-1 therapy, likely related to rapid weight loss rather than direct drug effects

These toxins can disrupt hormonal balance and interfere with normal metabolism, potentially leading to weight gain

Our findings underscore the possibility for wider applications for these medications but also highlight important risks that should be carefully monitored in people taking these drugs.

Researchers reveal benefits, risks linked to popular weight-loss drugs GLP-1 receptor agonists transform diabetes care, offering benefits to heart and brain health but posing risks to kidneys and pancreas Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart disease, and obesity

Also important are questions that explore diabetes control, symptoms that suggest hypothyroidism, history of previous surgery and medications (Tables 4, 5)